Ikeda K - Search Results

1

Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.

Ajani JA, Faust J, Ikeda K, Yao JC, Anbe H, Carr KL, Houghton M, Urrea P. Ajani JA, et al. Among authors: ikeda k. J Clin Oncol. 2005 Oct 1;23(28):6957-65. doi: 10.1200/JCO.2005.01.917. Epub 2005 Sep 6. J Clin Oncol. 2005. PMID: 16145066 Clinical Trial.

2

Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.

Takechi T, Okabe H, Ikeda K, Fujioka A, Nakagawa F, Ohshimo H, Kitazato K, Fukushima M. Takechi T, et al. Among authors: ikeda k. Oncol Rep. 2005 Jul;14(1):33-9. Oncol Rep. 2005. PMID: 15944764

3

Comparison of the pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients.

Comets E, Ikeda K, Hoff P, Fumoleau P, Wanders J, Tanigawara Y. Comets E, et al. Among authors: ikeda k. J Pharmacokinet Pharmacodyn. 2003 Aug;30(4):257-83. doi: 10.1023/a:1026142601822. J Pharmacokinet Pharmacodyn. 2003. PMID: 14650374 Free PMC article.

4

A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.

Daigo S, Takahashi Y, Fujieda M, Ariyoshi N, Yamazaki H, Koizumi W, Tanabe S, Saigenji K, Nagayama S, Ikeda K, Nishioka Y, Kamataki T. Daigo S, et al. Among authors: ikeda k. Pharmacogenetics. 2002 Jun;12(4):299-306. doi: 10.1097/00008571-200206000-00005. Pharmacogenetics. 2002. PMID: 12042667

5

Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats.

Yoshisue K, Masuda H, Matsushima E, Ikeda K, Nagayama S, Kawaguchi Y. Yoshisue K, et al. Among authors: ikeda k. Drug Metab Dispos. 2000 Oct;28(10):1162-7. Drug Metab Dispos. 2000. PMID: 10997934

6

Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.

Ikeda K, Yoshisue K, Matsushima E, Nagayama S, Kobayashi K, Tyson CA, Chiba K, Kawaguchi Y. Ikeda K, et al. Clin Cancer Res. 2000 Nov;6(11):4409-15. Clin Cancer Res. 2000. PMID: 11106261

7

Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.

Okuda H, Nishiyama T, Ogura K, Nagayama S, Ikeda K, Yamaguchi S, Nakamura Y, Kawaguchi K, Watabe T, Ogura Y. Okuda H, et al. Among authors: ikeda k. Drug Metab Dispos. 1997 Feb;25(2):270-3. Drug Metab Dispos. 1997. Corrected and republished in: Drug Metab Dispos. 1997 May;25(5):270-3. PMID: 9029059 Corrected and republished.

8

Population study of expression of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with solid tumors.

Fukushima M, Morita M, Ikeda K, Nagayama S. Fukushima M, et al. Among authors: ikeda k. Int J Mol Med. 2003 Dec;12(6):839-44. Int J Mol Med. 2003. PMID: 14612954

9

Second-Generation Energy Decomposition Analysis of Intermolecular Interaction Energies from the Second-Order Mo̷ller-Plesset Theory: An Extensible, Orthogonal Formulation with Useful Basis Set Convergence for All Terms.

Wang Z, Ikeda K, Shen H, Loipersberger M, Zech A, Aldossary A, Head-Gordon T, Head-Gordon M. Wang Z, et al. Among authors: ikeda k. J Chem Theory Comput. 2025 Jan 21. doi: 10.1021/acs.jctc.4c01301. Online ahead of print. J Chem Theory Comput. 2025. PMID: 39835661

10

The secret life of the Pyricularia fungi in the rhizosphere.

Xiang Z, Nakayashiki H, Ikeda K. Xiang Z, et al. Among authors: ikeda k. Fungal Biol. 2025 Feb;129(1):101524. doi: 10.1016/j.funbio.2024.101524. Epub 2024 Dec 5. Fungal Biol. 2025. PMID: 39826979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,204 results

Search Page

Filters